Abstract:Background Chronic hepatitis B is a primary cause of liver-related death. Interferon alpha (IFN-α) is able to inhibit the replication of hepadnavirus, and the sustained and stable expression of IFN-α at appropriate level may be beneficial to HBV clearance. With the development of molecular cloning technology, gene therapy plays a more and more important role in clinical practice. In light of the findings, an attempt to investigate the anti-HBV effects mediated by a eukaryotic expression plasmid (pSecTagB-IFN-α) in vitro was carried out. Methods HBV positive cell line HepG2.2.15 and its parental cell HepG2 were transfected with pSecTagB-IFN-α or empty plasmid by using Lipofectamine™ 2000 reagent. The expression levels of IFN-α were determined by reverse transcriptase polymerase chain reaction (RT-PCR) and ELISA methods. The effects of pSecTagB-IFN-α on HBV mRNA, DNA and antigens were analyzed by real-time fluorescence quantitative PCR (qRT-PCR) and ELISA assays. RT-PCR, qRT-PCR and western blot were employed to investigate the influence of pSecTagB-IFN-α on IFN-α-induced signal pathway. Furthermore, through qRT-PCR and ELISA assays, the suppressive effects of endogenously expressed IFN-α and the combination with lamivudine on HBV were also examined. Results pSecTagB-IFN-α could express efficiently in hepatoma cells, and then inhibited HBV replication, characterized by the decrease of HBV S gene (HBs) and HBV C gene (HBc) mRNA, the reduction of HBV DNA load, and the low contents of hepatitis B surface antigen (HBsAg) and hepatitis B e antigen (HBeAg). Mechanism research showed that the activation of Janus kinase (JAK)-signal transducer and activator of transcription (STAT) signal pathway, the up-regulation of IFN-α-induced antiviral effectors and double-stranded (ds) RNA sensing receptors by delivering pSecTagB-IFN-α, could be responsible for these phenomena. Furthermore, pSecTagB-IFN-α vector revealed effectively anti-HBV effect than exogenously added IFN-α. Moreover, lamivudine combined with endogenously expressed IFN-α exhibited stronger anti-HBV effect than with exogenous IFN-α. Conclusion Our results showed that endogenously expressed IFN-α can effectively and persistently inhibit HBV replication in HBV infected cells. These observations opened a promising way to design new antiviral genetic engineering drugs based on IFN-α.

Cloning and Eukaryotic Expression of APOBEC3F and Its Anti-HBV Effect

Construction of Eukaryotic Expressional Vectors of APOBEC3G and the Effects on the Replication and Expression of HBV

Inhibition of Hepatitis B Virus Replication by APOBEC3G in Vitro and in Vivo.

Cloning and Eukaryotic Expression of APOBEC3G Gene of AIDS Patients

N-terminal and C-terminal Cytosine Deaminase Domain of APOBEC3G Inhibit Hepatitis B Virus Replication

HBeAg Precursor Proteins Interact with APOBEC3A and Inhibit HBV Replication

[Cloning,expression and Activity Identification of Human Innate Immune Protein Apolipoprotein B Mrna Editing Enzyme Catalytic Subunit 3A(APOBEC3A)].

[Expression and Activity Identification of APOBEC3A-HBc Fusion Protein].

APOBEC3G Directly Binds Hepatitis B Virus Core Protein in Cell and Cell Free Systems

[Expression and Subcellular Localization of APOBEC3G in Peripheral Blood Mononuclear Cells and Liver Tissues of Chronic HBV Patients].

Construction of a recombinant plasmid expressing HBV core antigen and A3C fusion protein

Hepatitis B virus X protein is capable of down-regulating protein level of host antiviral protein APOBEC3G

[Inhibitory Effect of a HBV Vector Plasmid Expressing A3C on HBV Replication].

Cytidine deaminase APOBEC3B interacts with heterogeneous nuclear ribonucleoprotein K and suppresses hepatitis B virus expression.

The Anti-Hbv Effect Mediated by a Novel Recombinant Eukaryotic Expression Vector for IFN-α

Young Investigator Session

Cell-specific Regulation of APOBEC3F by Interferons

Study on the effect of hepatitis B virus on the expression of apolipoprotein E

Potential Roles Of Placental Human Beta-Defensin-3 And Apolipoprotein B Mrna-Editing Enzyme Catalytic Polypeptide 3g In Prevention Of Intrauterine Transmission Of Hepatitis B Virus

Effects of APOBEC3G gene on biological behaviors of HepG2.2.15 cells

Inhibition of HBV Core Antigen Gene Expression in Human Embryonic Kidney Cell Line AD293 by Plasmid-Based RNAi